The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what GHK CU Program Calibrate Hydration GHK Cu Copper Peptide Research BioStrata Research GHK Cu Peptide Therapy Brea, CA Orange County Potential FDA Peptide Reclassification 2026 What It Means for Patients Beverly Hills Rejuvenation Center